Mohamad Mohty
Associate Editor at Blood Cancer Journal
Professor of Hematology; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.
Articles
-
2 months ago |
nature.com | Jaime Sanz |Myriam Labopin |Jurjen Versluis |Didier Blaise |Lorenzo Lazzari |Juan Montoro | +7 more
AbstractWe retrospectively analyzed the impact of conditioning intensity on transplant outcomes according to their cytogenetic/molecular risk in a cohort of 1823 patients with acute myeloid leukemia (AML) and intermediate- or adverse-risk cytogenetics in first complete remission (CR1). These patients received their first hematopoietic stem cell transplantation (HSCT) using post-transplant cyclophosphamide (PTCy).
-
2 months ago |
oncodaily.com | Mohamad Mohty
Mohamad Mohty, Chairman of the IACH, shared his recent article on X:Just published in Clinical Hematology International, the official peer-reviewed open access academic journal of The International Academy for Clinical Hematology (IACH). The journal welcomes your contributions: no submission fees or other hidden charges for academic authors. How to perform a high-quality peer reviewAuthors:
-
2 months ago |
chi.scholasticahq.com | Mohamad Mohty
-
Nov 23, 2024 |
chi.scholasticahq.com | Mohamad Mohty |Bipin N. Savani
In today’s digital age, social media has become a transformative force, significantly impacting the field of medicine. While traditionally known for face-to-face consultations and academic discussions, healthcare professionals are increasingly turning to platforms like X (formerly known as Twitter), Facebook, or LinkedIn (to mention just a few) to share knowledge, collaborate, and even enhance patient care.
-
Nov 7, 2024 |
myhematologia.pt | Mohamad Mohty
O hematologista Mohamad Mohty, do Saint-Antoine Hospital & Sorbonne University, foi o especialista internacional convidado do simpósio da Pfizer, integrado na Reunião Anual da Sociedade Portuguesa de Hematologia (SPH), de 7 de novembro. Sob o desígnio, “BCMA in Multiple Myeloma: Practical Management for Clinicians”, o hematologista sumarizou a evidência clínica relativa a anticorpos biespecíficos, destacando a sua eficácia, bem como o seu perfil de segurança.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 20K
- Tweets
- 37K
- DMs Open
- No
RT @Mohty_EBMT: Managing frail patients with blood diseases is a challenging task, balancing complex treatments with heightened risks and v…
Managing frail patients with blood diseases is a challenging task, balancing complex treatments with heightened risks and vulnerability. Don’t miss this webinar by @TheIACH Free registration: https://t.co/kb37E1bIKS @TheEBMT_Nurses @TheEBMT_CTIWP https://t.co/tyrcrcsNkr
RT @EMN_EuMMnet: ✨ #EMN2025 has just started in beautiful #Athens!🏛️ Enjoy the conference and interact with speakers! Registration for Meet…